HENNION & WALSH ASSET MANAGEMENT, INC. – Apellis Pharmaceuticals, Inc. Transaction History
HENNION & WALSH ASSET MANAGEMENT, INC. portfolio value:
$3.94M
portfolio value
HENNION & WALSH ASSET MANAGEMENT, INC. quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.35% | -3.26K shares | 1.18M | $68.3 | 57.71K |
| Q2 2022 | share | Decrease | -48.90% | -58.34K shares | -3.30M | $45.22 | 60.97K |
| Q1 2022 | share | Decrease | -12.75% | -17.43K shares | -403K | $50.81 | 119.32K |
| Q4 2021 | share | Decrease | -24.94% | -45.44K shares | 461K | $47.95 | 136.76K |
| Q3 2021 | share | Decrease | -3.42% | -6.45K shares | -5.91M | $32.96 | 182.20K |
| Q2 2021 | share | Increase | +8.39% | 14.6K shares | 4.45M | $63.2 | 188.65K |
| Q1 2021 | share | Increase | 0.00% | 174.05K shares | 7.46M | $42.91 | 174.05K |